Alzamend Neuro Partners With Massachusetts General Hospital for a Phase II Clinical Trial of Al001, a Next-Generation Lithium Therapeutic Drug Candidate, Involving Patients With Alzheimer’s Disease
Alzamend Neuro與麻省總醫院合作進行II期臨床試驗，研究Al001，一種下一代鋰礦治療藥物，涉及患有阿爾茨海默病的患者。